Acquisition of Bostik - Arkema波士胶的收购u2014u2014。阿科玛双氧水有限公司遵循严格的.pdfVIP

Acquisition of Bostik - Arkema波士胶的收购u2014u2014。阿科玛双氧水有限公司遵循严格的.pdf

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
Acquisition of Bostik - Arkema波士胶的收购u2014u2014。阿科玛双氧水有限公司遵循严格的

Acquisition of Bostik A key milestone in Arkema ’s strategy September 19th , 2014 A perfect opportunity Acquisition of Bostik #3 worldwide in adhesives with €1.53bn sales • Attractive adhesives market • Strong leadership positions, brands and technology know-how • Proven earning resilience • Opportunity followed since several years Full alignment with Arkema’s strategy • Accelerate expansion in High Performance Materials • Reinforce earning stability • Enhance market-driven approach through long-term partnerships, unique technologies and geographical footprint Strong improvement potential • Current margin below peers (10.3%): 14 to 15% long-term EBITDA margin target • Well-identified synergies Strong confidence in execution • In-depth understanding of Bostik business • Common DNA and historical roots within Total • Successful track-record of Arkema in turning around businesses A major step in building a world leader in specialty chemicals 2 Project subject to the authorization of the relevant antitrust authorities and information/consultation of work councils Transaction highlights Bostik key figures €1.53bn sales (2014e) €158m EBITDA and 10.3% EBITDA margin Capex: 3% of sales Value creation Cash accretion from first full year; EPS accretive from 2nd year Acceleration of Bostik growth with strong margin improvement planned Well-identified synergies +30% EBITDA in next 3 years not taking into account development synergies on Arkema current business Considerati

您可能关注的文档

文档评论(0)

wnqwwy20 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:7014141164000003

1亿VIP精品文档

相关文档